NV Therapeutics
PrivateLast Round
Seed
Mar 13, 2025
Total Funding Raised
$3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NV Therapeutics is a biotechnology company that develops non-viral gene editing technology to revolutionize cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NV Therapeutics Comparables
Compare NV Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SonoThera | 47% | |
| Spot Biosystems | 44% | |
| Komo Biosciences | 44% |
For institutional investors. Book with your work email.
NV Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 13, 2025 | ||||
| Seed | Sep 13, 2024 |
For institutional investors. Book with your work email.
NV Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 4BIO Capital | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 119% MoM.
- Apr 23, 2026
Monthly visitors increased 324% MoM.
For institutional investors. Book with your work email.
NV Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NV Therapeutics's valuation, stock price, and market status.
Is NV Therapeutics a public or private company?
NV Therapeutics is a private company.
What is the current stock price of NV Therapeutics?
NV Therapeutics is a private company, so its shares have no public market price. Caplight tracks NV Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NV Therapeutics worth (valuation)?
Valuation information for NV Therapeutics is not publicly available.
Can I buy NV Therapeutics stock?
NV Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NV Therapeutics's last funding round?
NV Therapeutics's most recent funding round was Seed on March 13, 2025.
Who are the main investors in NV Therapeutics?
Key investors in NV Therapeutics include 4BIO Capital.
Will NV Therapeutics IPO soon?
No public IPO plans have been announced for NV Therapeutics.
How can I track NV Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in NV Therapeutics's shares on secondary markets.